Prevalence of Pressure Ulcers Among Critically Ill Patients and Factors Associated With Their Occurrence in the ICU (PRESSURE)

April 10, 2019 updated by: French Society for Intensive Care
The prevalence of and risk factors for pressure ulcers (PUs) in critically ill patients have been poorly studied. The main objective of this study was to describe the prevalence of PUs in critically ill patients. Secondary objectives were to describe PUs, means of prevention of PUs, and factors associated with occurrence of PUs in the ICU.

Study Overview

Detailed Description

Pressure ulcers (PUs) among hospitalized patients are associated with a poor prognosis and with a high cost of care. Hospitalization in the ICU is a context where there is a high risk of occurrence of PUs, prevention of which is a priority for ICU teams caring for critically ill patients. However, the literature is inconclusive regarding the prevalence of PUs among critically ill patients and the associated risk factors. The main objective of this study was to describe the prevalence of PUs among critically ill patients hospitalized in the ICU. Secondary objectives were to describe means of prevention of PUs in the ICU and the characteristics of PUs, and to identify factors either related to the ICU or patient characteristics associated with occurrence of PUs in the ICU.

Study Type

Observational

Enrollment (Actual)

1228

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Agen, France, 47923
        • Hôpital Saint-Esprit
      • Angers, France, 49000
        • CHU d'Angers
      • Antony, France, 92166
        • Hopital Prive d'Antony
      • Ars-Laquenexy, France, 57245
        • Hopital Mercy
      • Belfort, France, 90015
        • Hopital Nord Franche Comte
      • Bobigny, France, 93000
        • Hôpital Avicenne
      • Bordeaux, France, 33000
        • CHU Pellegrin
      • Bordeaux, France, 33075
        • Hopital St-Andre
      • Boulogne Billancourt, France, 92100
        • Hôpital Ambroise Paré
      • Brest, France, 29240
        • HIA Clermont Tonnerre
      • Clamart, France, 92140
        • Hôpital Antoine Béclère
      • Clamart, France, 92190
        • HIA Percy
      • Colombes, France, 92700
        • Hopital Louis Mourier
      • Corbeil-Essonnes, France, 91100
        • Groupe Hospitalier Sud Ile de France
      • Cornebarrieu, France, 31700
        • Clinique des Cèdres
      • Creteil, France, 94010
        • CHU Henri Mondor
      • Dijon, France, 21709
        • CHU Dijon Bourgogne
      • Eaubonne, France, 95600
        • Hôpital Simone Veil
      • Garches, France, 92380
        • Hopital Raymond Poincare
      • Grenoble, France, 38700
        • Chu Grenoble Alpes
      • Jossigny, France, 77600
        • Grand Hôpital de l'Est Francilien
      • La Réunion, France, 97400
        • CHU Réunion Saint Pierre
      • Le Kremlin-Bicêtre, France, 94270
        • CHU Kremlin-Bicêtre
      • Lille, France, 59037
        • Hôpital Roger Salengro
      • Lyon, France, 69003
        • HIA Desgenettes Lyon
      • Lyon, France, 69437
        • Groupe Hospitalier Edouard Herriot
      • Mantes-la-Jolie, France, 78200
        • Hopital Francois Quesnay
      • Marseille, France, 13385
        • Hôpital de la Timone
      • Marseille, France, 13003
        • Hôpital Européen Marseille
      • Marseille, France, 13015
        • CHU Marseille Hopital Nord
      • Metz, France, 57038
        • Hopital Notre-Dame de Bon Secours
      • Montfermeil, France, 93370
        • GHIRM
      • Montpellier, France, 34090
        • CHU Lapeyronie
      • Nancy, France, 54035
        • CHU Nancy
      • Nantes, France, 44000
        • CHU Nantes
      • Nantes, France, 44035
        • Hopital Laennec
      • Nice, France, 06202
        • Hôpital l'Archet
      • Nîmes, France, 30029
        • CHU Nîmes
      • Paris, France, 75014
        • Institut Mutualiste Montsouris
      • Paris, France, 75020
        • Hopital Tenon
      • Paris, France, 75014
        • COCHIN
      • Paris, France, 75010
        • Hôpital St Louis
      • Paris, France, 75013
        • La Pitié Salpêtrière
      • Paris, France, 75015
        • HEGP
      • Paris, France, 75012
        • GH Diaconnesses Croix Saint Simon
      • Paris, France, 75015
        • CHU Necker Enfants Malades
      • Paris, France, 75015
        • CHU Robert Debré
      • Poitiers, France, 86021
        • CHU Poitiers
      • Quincy-sous-Sénart, France, 91480
        • Hôpital privé Claude Galien
      • Saint-Jean, France, 31240
        • Clinique de l'Union
      • St-Denis, France, 93200
        • Hopital DELAFONTAINE
      • St-Mande, France, 94160
        • HIA Béjin
      • Strasbourg, France, 67200
        • CHU Strasbourg
      • Sète, France, 34200
        • Hôpital Saint Clair
      • Toulouse, France, 31400
        • CHU TOULOUSE Rangueil
      • Tremblay-en-France, France, 93290
        • Hopital Privé du Vert Galan
      • Valenciennes, France, 59322
        • Hopital Jean Bernard
      • Villejuif, France, 94805
        • Institut Gustave Roussy
      • Villenave-d'Ornon, France, 33140
        • HIA Robert Pique
      • Yerres, France, 91330
        • Hopital Privé du Val d'Yerres

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient in Critical Care during study day.

Description

The inclusion criteria were :

  • hospitalization in the ICU
  • age ≥ 18 years.

The exclusion criterion was:

- refusal to participate in the study by the patient or by the patient's family when the patient was unable to consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure Ulcer Presence on the study day
Time Frame: Through study completion, an average of 1 day
Presence (1) or absence (0) of pressure ulcer (however grade of pressure ulcer) during the study period which is a 1 Day Study Prevalence
Through study completion, an average of 1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Grade of Pressure Ulcer on the study day
Time Frame: Through study completion, an average of 1 day
Grade (from 1 to 4) of pressure ulcer during the study period which is a 1 Day Study Prevalence
Through study completion, an average of 1 day
Area of Pressure Ulcer on the study day
Time Frame: Through study completion, an average of 1 day
Area on the patient's body of pressure ulcer during the study period which is a 1 Day Study Prevalence
Through study completion, an average of 1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Gael Piton, MD, PhD, French Intensive Care Society

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 1, 2017

Primary Completion (ACTUAL)

June 1, 2017

Study Completion (ACTUAL)

December 1, 2017

Study Registration Dates

First Submitted

April 8, 2019

First Submitted That Met QC Criteria

April 10, 2019

First Posted (ACTUAL)

April 11, 2019

Study Record Updates

Last Update Posted (ACTUAL)

April 11, 2019

Last Update Submitted That Met QC Criteria

April 10, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • PRESSURE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Care

Clinical Trials on Pressure Ulcer Evaluation

Subscribe